Fulgent Genetics (FLGT) Change in Receivables (2015 - 2026)

Fulgent Genetics has disclosed Change in Receivables across 12 years of filings, most recently posting -$729000.0 for Q2 2026.

• In Q2 2026, Change in Receivables fell 108.83% year-over-year to -$729000.0; the TTM figure through Jun 2026 stood at -$6.7 million (down 124.16% YoY), while the FY2025 annual figure was $23.3 million, up 42.62% from the prior year.
• Change in Receivables came in at -$729000.0 for Q2 2026 at Fulgent Genetics, up from -$16.4 million in the prior quarter.
• In the past five years, Change in Receivables ranged from a high of $32.9 million in Q1 2022 to a low of -$44.4 million in Q4 2022.
• Average Change in Receivables over 5 years is -$2.7 million, with a median of $428000.0 recorded in 2024.
• Year-over-year, Change in Receivables soared 404.85% in 2025 and sank 463.2% in 2026.
• Over 5 years, Change in Receivables stood at -$44.4 million in 2022, then jumped by 111.72% to $5.2 million in 2023, then soared by 155.86% to $13.3 million in 2024, then grew by 15.4% to $15.4 million in 2025, then slumped by 104.74% to -$729000.0 in 2026.
• Per Business Quant data, the three most recent Change in Receivables figures were -$729000.0 in Q2 2026, -$16.4 million in Q1 2026, and $15.4 million in Q4 2025.